A drug interaction study investigating the effect of Rifabutin on the pharmacokinetics of Maraviroc in healthy subjects

Effects of steady-state rifabutin on the pharmacokinetics of steady-state maraviroc were investigated in fourteen healthy adult female and male volunteers. Maraviroc 300 mg twice daily (BID) was given orally with food for fifteen days. On day six, rifabutin 300 mg once daily (QD, P.O.) was added to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghannad, M., Dennehy, M., la Porte, C., Seguin, I., Tardiff, D., Mallick, R., Sabri, E., Zhang, G., Kanji, S., Cameron, D. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812819/
https://www.ncbi.nlm.nih.gov/pubmed/31647836
http://dx.doi.org/10.1371/journal.pone.0223969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812819/
https://www.ncbi.nlm.nih.gov/pubmed/31647836
http://dx.doi.org/10.1371/journal.pone.0223969

Ejemplares similares